These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

102 related articles for article (PubMed ID: 4002199)

  • 1. Involvement of disulfide-sulfhydryl interaction in anti-platelet actions of KF4939.
    Yamada K; Kubo K; Shuto K; Nakamizo N
    Thromb Res; 1985 Apr; 38(1):61-9. PubMed ID: 4002199
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Evidence that KF4939, a new anti-platelet agent, inhibits phospholipase activation in rabbit platelets: different aspects from cyclic AMP increasing agents and calmodulin antagonist.
    Yamada K; Shuto K; Kubo K; Nakamizo N
    Arch Int Pharmacodyn Ther; 1984 Mar; 268(1):141-54. PubMed ID: 6329114
    [TBL] [Abstract][Full Text] [Related]  

  • 3. KF4939, a new anti-platelet agent, inhibits activation of phospholipase C and A2 in rabbit platelets.
    Yamada K; Kumada Y; Kubo K
    Jpn J Pharmacol; 1985 Sep; 39(1):108-11. PubMed ID: 3934441
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The role of protein sulfhydryl groups and protein disulfides of the platelet surface in aggregation processes involving thiol exchange reactions.
    Margaritis A; Priora R; Frosali S; Di Giuseppe D; Summa D; Coppo L; Di Stefano A; Di Simplicio P
    Pharmacol Res; 2011 Jan; 63(1):77-84. PubMed ID: 20883787
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Inhibition of platelet aggregation by a new agent, 2,2'-dithiobis-(N-2-hydroxypropyl benzamide) (KF4939).
    Yamada K; Shuto K; Nakamizo N
    Thromb Res; 1983 Jan; 29(2):197-206. PubMed ID: 6405499
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Inhibition of thromboxane A2-induced vasocontraction by KF4939, a new anti-platelet agent, in rabbit mesenteric and dog coronary arteries.
    Yamada K; Kubo K; Shuto K; Nakamizo N
    Jpn J Pharmacol; 1984 Nov; 36(3):283-90. PubMed ID: 6521073
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Effect of compounds causing reversible perturbation of the cellular thiol-disulfide status on the aggregation of human blood platelets.
    Hofmann J; Lösche W; Hofmann B; Arese P; Bosia A; Pescarmona G; Till U
    Biomed Biochim Acta; 1983; 42(5):479-87. PubMed ID: 6418155
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Redox control of platelet aggregation.
    Essex DW; Li M
    Biochemistry; 2003 Jan; 42(1):129-36. PubMed ID: 12515547
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The influence of glutathione and other thiols on human platelet aggregation.
    Thomas G; Skrinska VA; Lucas FV
    Thromb Res; 1986 Dec; 44(6):859-66. PubMed ID: 3099423
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Difference in inhibitory actions of products of the myeloperoxidase- catalyzed reaction on initial aggregation of activated platelets].
    Rpshchupkin DI; Berzhitskaia VV; Murina MA
    Biofizika; 1998; 43(2):323-8. PubMed ID: 9591107
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The role of thiols and disulfides in platelet function.
    Essex DW
    Antioxid Redox Signal; 2004 Aug; 6(4):736-46. PubMed ID: 15242555
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Extracts of feverfew may inhibit platelet behaviour via neutralization of sulphydryl groups.
    Heptinstall S; Groenewegen WA; Spangenberg P; Loesche W
    J Pharm Pharmacol; 1987 Jun; 39(6):459-65. PubMed ID: 2886604
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Sulfhydryl/disulfide-status of blood platelets--a target for pharmacological intervention?
    Till U; Bergmann I; Breddin K; Heptinstall S; Lösche W; Mazurov A; Pescarmona G
    Prog Clin Biol Res; 1989; 301():341-5. PubMed ID: 2678129
    [No Abstract]   [Full Text] [Related]  

  • 14. Effects of cephalothin and penicillin G on platelet function in vitro.
    Cazenave J-P ; Guccione MA; Packham MA; Mustard JF
    Br J Haematol; 1977 Jan; 35(1):135-52. PubMed ID: 869992
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Effect of heparin on platelet monolayer adhesion, aggregation and production of malondialdehyde.
    Davies JA; Menys VC
    Thromb Res; 1982 Apr; 26(1):31-41. PubMed ID: 7101245
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Role of reduced glutathione on platelet functions.
    Matsuda S; Ikeda Y; Aoki M; Toyama K; Watanabe K; Ando Y
    Thromb Haemost; 1979 Dec; 42(4):1324-31. PubMed ID: 542937
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Protein S-glutathionylation and platelet anti-aggregating activity of disulfiram.
    Rossi R; Giustarini D; Dalle-Donne I; Milzani A
    Biochem Pharmacol; 2006 Aug; 72(5):608-15. PubMed ID: 16815310
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Modification of platelet functions by monobromobimane, a fluorescent thiol group label.
    Zucker MB; Mauss EA
    Thromb Haemost; 1986 Apr; 55(2):228-34. PubMed ID: 3012818
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Localization of fibrinogen during ADP- or thrombin-induced aggregation of washed rabbit platelets.
    Suzuki H; Kinlough-Rathbone RL; Packham MA; Mustard JF; Tanoue K; Yamazaki H
    J Histochem Cytochem; 1990 Jun; 38(6):869-74. PubMed ID: 2335742
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Superoxide dismutase cooperates with prostacyclin to inhibit platelet aggregation: a comparative study in washed platelets and platelet rich plasma.
    Salvemini D; de Nucci G; Vane JR
    Thromb Haemost; 1991 Apr; 65(4):421-4. PubMed ID: 1647553
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.